ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Obagi Medical Products, Inc. (MM)

Obagi Medical Products, Inc. (MM) (OMPI)

23.98
0.00
( 0.00% )
Updated: 19:00:00

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

OMPI News

Official News Only

OMPI Discussion

View Posts
BooDog BooDog 12 years ago
Far out. Gives my little guys some hope
congrats!!
👍️0
ospreyeye ospreyeye 12 years ago
OMPI Chart.......Gapper.......huge move today...............$$$

👍️0
Edgenation Edgenation 12 years ago
Ok just sold because of revenue/inventory numbers. I'll be back someday!
👍️0
Edgenation Edgenation 12 years ago
Haha no, just saying that would be nice! but intermediate to long term there is a good chance. We shall see!
👍️0
mlkrborn mlkrborn 12 years ago
In a week?
GL
mlkr
👍️0
Edgenation Edgenation 12 years ago
Just got in today at $14.53. Pretty dead board but the company has great near term potential with a possible buyout still! hopefully this runs to $20 in a week!
👍️0
mlkrborn mlkrborn 13 years ago
Obagi Medical: Addresses response by Obagi Board of Directors to its letter says 'Voce commends Obagi's appointment of strategic advisors, and further welcomes its public commitment that any acquisition offers' (OMPI) 11.87 : The letter stated "On February 10, 2012, Voce sent a letter to the Obagi Board of Directors criticizing the Board's recent adoption of a poison pill and demanding immediate action to address corporate governance deficiencies and to evaluate strategic alternatives. Voce's letter stated that it believed Obagi has spurned recent overtures to acquire the Company. On February 14, 2012, the Obagi Board responded to Voce's letter. The Board's statement notably did not dispute Voce's claims that the Company had recently received and summarily rebuffed offers to acquire Obagi. In addition, the Obagi Board's response states in part: Voce commends Obagi's appointment of strategic advisors, and further welcomes its public commitment that any acquisition offers from this point forward will be reviewed by these independent advisors. Voce believes that this change in Obagi's posture may invite additional acquisition interest....There is substantial strategic interest in an acquisition of Obagi and broad support for a sale of the Company in both the investment and the analyst community. It behooves the Obagi Board to pursue this potential outcome diligently."
👍️0
mlkrborn mlkrborn 15 years ago
Too bad no one covered but up since its creation: Chart!
http://stockcharts.com/h-sc/ui?s=ompi&p=D&yr=0&mn=6&dy=0&id=p97690170109
👍️0
kmx_swing kmx_swing 16 years ago
OMPI board created
👍️0